Pornpit Treebupachatsakul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pornpit Treebupachatsakul has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Akarawat Kornjirakasemsan
Pharmacy Department, Nakornping Hospital, Chiang Mai, Thailand
1 shared publication - Anamai Na-Udom
Department of Mathematics, Faculty of Science, Naresuan University, Phitsanulok, Thailand
1 shared publication - Anong Kiddee
Division of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao, 56000, Thailand; Unit of Excellence on Research and Application of Natural Products for Health and Well-Being, University of Phayao, Phayao, 56000, Thailand
1 shared publication - Jaruwan Diewsurin
Department of Medicine, Buddhachinaraj Hospital , Phitsanulok
1 shared publication Kanit Assawatheptawee
Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand
1 shared publication- Pannika Ritvirool Niumsup
Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand
1 shared publication
Latest Publications
- Open Access
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
2729. Clinical characteristics, treatment and outcomes of infections among adult-onset immunodeficiency with anti-interferon (IFN)-γ autoantibodies patients: A single-center 10-year review from tertiary care hospital in Thailand
Adult-onset immunodeficiency (AOI) with anti-interferon (IFN)-γ autoantibodies is an acquired immunodeficiency syndrome increasingly recognized in East and Southeast Asia. Antibody against IFN- γ or its receptor is the main pathophysiology leading to opportunistic infections especially mycobacterial, dimorphic fungal or Salmonella infection. However, clinical information of infectious complications in this patient population remains scarce. A retrospective study was conducted in Buddhachinaraj hospital, Phitsanuloke, Thailand. We collected data on demographic, infectious complications, treatment and outcomes in patients with AOI with anti-IFN-γ autoantibodies who presented to our center between March 2013 and February 2023. All patients were diagnosed by elevation of anti-IFN- γ antibody level in serum more than 1.0. A total of 35 patients. 54.3% were men with a median age of 58 years (IQR 14-63). Lymphadenopathy was the most common initial presentation (57%), followed by prolonged fever (40%), cough (11%) and skin lesions (11%). Lymph node involvement was found in 80% while 31% and 11% had intra-abdominal abscess and osteomyelitis. Organisms were identified in 21 patients (60%). Mycobacterial infections were found in 19 patients (90%) which the main etiologic agent was Mycobacterium abscessus (43%). Six patients (28%) had evidence of mycobacterial infection but were unable to specified. Histoplasma capsulatum was found in 2 patients (9%). Another 14 patients (40%) were presumptive treated as non-tuberculous mycobacterium (NTM) infection without retrieving specific organism. All patients were treated with antimicrobial agents according to identified causative organism. Fourteen patients with presumptive NTM infection were empirically treated with combination antibiotics. Median time of treatment was 24 months (IQR 12-35). Seven patients (20%) experienced relapse after antimicrobial discontinuation requiring retreatment. Three patients (6%) had died at median duration of 4 months from diagnosis. AOI with (IFN)-γ autoantibodies should be considered in patient whom suspected mycobacterium or fungal infection among non-HIV patients. Diagnosis and treatment are challenge and recurrent infection is common. All Authors: No reported disclosures
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
Open Access2729. Clinical characteristics, treatment and outcomes of infections among adult-onset immunodeficiency with anti-interferon (IFN)-γ autoantibodies patients: A single-center 10-year review from tertiary care hospital in Thailand
Adult-onset immunodeficiency (AOI) with anti-interferon (IFN)-γ autoantibodies is an acquired immunodeficiency syndrome increasingly recognized in East and Southeast Asia. Antibody against IFN- γ or its receptor is the main pathophysiology leading to opportunistic infections especially mycobacterial, dimorphic fungal or Salmonella infection. However, clinical information of infectious complications in this patient population remains scarce. A retrospective study was conducted in Buddhachinaraj hospital, Phitsanuloke, Thailand. We collected data on demographic, infectious complications, treatment and outcomes in patients with AOI with anti-IFN-γ autoantibodies who presented to our center between March 2013 and February 2023. All patients were diagnosed by elevation of anti-IFN- γ antibody level in serum more than 1.0. A total of 35 patients. 54.3% were men with a median age of 58 years (IQR 14-63). Lymphadenopathy was the most common initial presentation (57%), followed by prolonged fever (40%), cough (11%) and skin lesions (11%). Lymph node involvement was found in 80% while 31% and 11% had intra-abdominal abscess and osteomyelitis. Organisms were identified in 21 patients (60%). Mycobacterial infections were found in 19 patients (90%) which the main etiologic agent was Mycobacterium abscessus (43%). Six patients (28%) had evidence of mycobacterial infection but were unable to specified. Histoplasma capsulatum was found in 2 patients (9%). Another 14 patients (40%) were presumptive treated as non-tuberculous mycobacterium (NTM) infection without retrieving specific organism. All patients were treated with antimicrobial agents according to identified causative organism. Fourteen patients with presumptive NTM infection were empirically treated with combination antibiotics. Median time of treatment was 24 months (IQR 12-35). Seven patients (20%) experienced relapse after antimicrobial discontinuation requiring retreatment. Three patients (6%) had died at median duration of 4 months from diagnosis. AOI with (IFN)-γ autoantibodies should be considered in patient whom suspected mycobacterium or fungal infection among non-HIV patients. Diagnosis and treatment are challenge and recurrent infection is common. All Authors: No reported disclosures
- Open Access
- 18 May 2023
- Published by XMLink in Infection & Chemotherapy
- Vol. 55 (2) , 226-236
Incidence and Risk Factors of Tenofovir Disoproxil Fumarate Induced Nephrotoxicity and Renal Function Recovery, a Hospital Case-Control Study
Srisopa S, et al. Infect Chemother. 2023 May;55:e19. https://doi.org/10.3947/ic.2023.0001
- 18 May 2023
- Published by XMLink in Infection & Chemotherapy
- Vol. 55 (2) , 226-236
Open AccessIncidence and Risk Factors of Tenofovir Disoproxil Fumarate Induced Nephrotoxicity and Renal Function Recovery, a Hospital Case-Control Study
Srisopa S, et al. Infect Chemother. 2023 May;55:e19. https://doi.org/10.3947/ic.2023.0001
- 1 October 2019
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 25 (8) , 1182-1190
Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand
Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are important causes of serious infections in intensive care unit (ICU). This study aimed to investigate the risk factors for intestinal carriage of ESBL-PE among patients admitted to ICU, subsequent ESBL-PE infections, and outcomes of these patients. This study prospectively collected rectal swabs from 215 ICU patients in Northern Thailand and ESBL-PE were isolated. A high prevalence of ESBL-PE carriage (134/215, 62.3%) at ICU admission was observed, with Escherichia coli representing the predominant organism (67.5%) followed by Klebsiella pneumoniae (19.4%). Multivariate logistic regression analysis identified chronic renal disease as the independent risk factor for ESBL-PE carriage ( p = 0.009; adjusted odds ratio = 4.369; 95% confidence interval = 1.455–13.119). Among colonized patients, 2.2% (3/134) developed ESBL-PE infections during ICU stay. Phylogenetic analysis of E. coli ( n = 108) showed that the predominant group was group A (38.0%), followed by groups B1 (17.6%), D (15.7%), B2 (14.8%), C (7.4%), and F (6.5%). Multilocus sequence typing analysis of the pathogenic groups B2, D, and F revealed 11 different sequence types (STs), with ST131 ( n = 13) as the most prevalent, followed by ST648 ( n = 5), ST38 ( n = 4), ST393 ( n = 3), and ST1193 ( n = 3). These results are of concern since ESBL-PE may be a prerequisite for endogenous infections and potentially disseminate within the hospital. This is the first study describing ESBL-PE carriage among patients at ICU admission and subsequent ESBL-PE infections in Thailand.
- 1 October 2019
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 25 (8) , 1182-1190
Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand
Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) are important causes of serious infections in intensive care unit (ICU). This study aimed to investigate the risk factors for intestinal carriage of ESBL-PE among patients admitted to ICU, subsequent ESBL-PE infections, and outcomes of these patients. This study prospectively collected rectal swabs from 215 ICU patients in Northern Thailand and ESBL-PE were isolated. A high prevalence of ESBL-PE carriage (134/215, 62.3%) at ICU admission was observed, with Escherichia coli representing the predominant organism (67.5%) followed by Klebsiella pneumoniae (19.4%). Multivariate logistic regression analysis identified chronic renal disease as the independent risk factor for ESBL-PE carriage ( p = 0.009; adjusted odds ratio = 4.369; 95% confidence interval = 1.455–13.119). Among colonized patients, 2.2% (3/134) developed ESBL-PE infections during ICU stay. Phylogenetic analysis of E. coli ( n = 108) showed that the predominant group was group A (38.0%), followed by groups B1 (17.6%), D (15.7%), B2 (14.8%), C (7.4%), and F (6.5%). Multilocus sequence typing analysis of the pathogenic groups B2, D, and F revealed 11 different sequence types (STs), with ST131 ( n = 13) as the most prevalent, followed by ST648 ( n = 5), ST38 ( n = 4), ST393 ( n = 3), and ST1193 ( n = 3). These results are of concern since ESBL-PE may be a prerequisite for endogenous infections and potentially disseminate within the hospital. This is the first study describing ESBL-PE carriage among patients at ICU admission and subsequent ESBL-PE infections in Thailand.